Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complete remission in plasma cell leukaemia.

C Montecucco, A Riccardi, G Merlini

    British Journal of Haematology
    |March 1, 1986
    PubMed
    Summary

    Two patients with primary plasma cell leukaemia achieved complete remission using intravenous Peptichemio combined with chemotherapy. This treatment approach shows potential for inducing remission in this aggressive blood cancer.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus.

    Lupus·2019
    Same author

    Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study.

    Clinical and experimental medicine·2019
    Same author

    Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.

    Lupus·2017
    Same author

    Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.

    Cancer chemotherapy and pharmacology·2015
    Same author

    Identification of the hydration state in emergency patients: correlation between caval index and BUN/creatinine ratio.

    European review for medical and pharmacological sciences·2013
    Same author

    DNA-ploidy and proliferative activity in uterine-tumors - an in-vivo study using bromodeoxyuridine and flow-cytometry.

    Oncology reports·2011

    Area of Science:

    • Hematology
    • Oncology
    • Pharmacology

    Background:

    • Primary plasma cell leukaemia is an aggressive hematologic malignancy.
    • Effective treatment options for plasma cell leukaemia remain limited.
    • Complete remission rates in plasma cell leukaemia are historically low.

    Observation:

    • Two patients with primary plasma cell leukaemia were treated with a novel induction regimen.
    • The regimen included intravenous Peptichemio, a multipeptide derivative of sarcolysin, combined with vincristine and/or prednisone.
    • This was followed by conventional melphalan-prednisone therapy.

    Findings:

    • Both patients achieved complete remission within 5-7 months of initiating therapy.
    • Remission durations were 23 and 6 months, respectively.
    • Survival times from the start of therapy were 57 and 16 months.

    Implications:

    • Intravenous alkylating agents, such as Peptichemio, can induce complete remission in plasma cell leukaemia.
    • This treatment strategy may offer a new therapeutic avenue for patients with this rare and aggressive leukaemia.
    • Further investigation into intravenous alkylating agents for plasma cell leukaemia is warranted.

    Related Experiment Videos